Pitavastatin Calcium

Pitavastatin Calcium, a medication used to lower cholesterol levels, has been the subject of several clinical trials to evaluate its safety, efficacy, and potential applications in various medical conditions. These trials have explored its effects on glucose metabolism, lipid profiles, and its potential use in treating conditions such as glioblastoma. This article summarizes key findings from recent clinical trials involving Pitavastatin Calcium.

Table of Contents

What is Pitavastatin Calcium?

Pitavastatin Calcium, also known by the brand name LIVALO[1] or Alipza[2], is a medication that belongs to a class of drugs called statins. Statins are commonly used to lower cholesterol levels in the blood. Pitavastatin works by reducing the amount of cholesterol produced by the liver, which helps to manage various conditions related to high cholesterol and blood fats (lipids).

Uses of Pitavastatin Calcium

Pitavastatin Calcium is primarily used to treat the following conditions:

  • Hyperlipidemia: This is a condition characterized by high levels of fats (lipids) in the blood, including cholesterol and triglycerides[1].
  • Dyslipidemia: A disorder of lipoprotein metabolism, including lipoprotein overproduction or deficiency[3].
  • Prediabetes: A condition where blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes[3].
  • Hypertension: High blood pressure, often associated with cardiovascular risks[3].

Dosage and Administration

Pitavastatin Calcium is typically taken orally in tablet form. The dosage can vary depending on the specific condition being treated and the individual patient’s needs. Some common dosages include:

  • 2 mg once daily[1]
  • 4 mg once daily[1]

In some clinical trials, higher doses of up to 48 mg daily have been studied for specific purposes[2]. However, it’s important to note that the dosage should always be determined by a healthcare professional based on individual patient factors and treatment goals.

Effects on Blood Sugar Levels

One of the key areas of research for Pitavastatin Calcium is its effect on blood sugar levels, particularly in patients with prediabetes or at risk of developing diabetes. Studies have been conducted to evaluate:

  • Changes in HbA1c levels (a measure of long-term blood sugar control)[3]
  • Changes in fasting plasma glucose (FPG) levels[3]
  • Changes in oral glucose tolerance test (OGTT) results[3]

These studies aim to determine if Pitavastatin has a more favorable effect on glucose metabolism compared to other statins, potentially making it a preferred choice for patients with or at risk of diabetes[3].

Other Potential Benefits

Research suggests that Pitavastatin Calcium may have additional benefits beyond cholesterol reduction:

  • Improvement in inflammatory markers, such as C-reactive protein (CRP)[3]
  • Potential reduction in cardiovascular disease (CVD) events[3]
  • Possible improvements in vascular endothelial function and arterial stiffness[3]
  • Potential effects on heart structure, as measured by left ventricular mass index (LVMI)[3]
  • Possible reduction in carotid intima-media thickness (CIMT), a marker of atherosclerosis[3]

Side Effects and Safety

As with all medications, Pitavastatin Calcium can cause side effects. Common side effects may include muscle pain, headache, and digestive issues. However, the specific side effect profile is being studied in ongoing clinical trials[3].

It’s important for patients to report any unusual symptoms or side effects to their healthcare provider. Regular monitoring of liver function and muscle enzymes may be recommended while taking this medication.

Ongoing Research

Pitavastatin Calcium is the subject of ongoing research to explore its potential in various medical conditions:

  • Glioblastoma: A phase 0 trial is investigating whether Pitavastatin can reach effective concentrations in brain tumor tissue, potentially opening new avenues for cancer treatment[2].
  • Prediabetes and Hypertension: Studies are comparing Pitavastatin to other statins like Atorvastatin to assess its effects on glucose metabolism and cardiovascular risk factors in patients with prediabetes and high blood pressure[3].

These ongoing studies aim to provide more information about the potential uses and benefits of Pitavastatin Calcium in various patient populations.

Trial Focus Key Findings/Objectives Dosage
Hyperlipidemia and Impaired Fasting Glucose Evaluating effect on HbA1c, lipid composition, and cardiovascular events 2mg and 4mg daily
Glioblastoma Assessing intratumoral concentration and potential synergy with temozolomide 16mg, 32mg, or 48mg daily
Prediabetes and Hypertension Comparing effects on glucose metabolism with Atorvastatin 2mg daily, potentially increased to 4mg

Ongoing Clinical Trials on Pitavastatin Calcium

  • Study on the Effect of Genetic Testing and Training on Muscle Side Effects in Patients Taking Statins for Cardiovascular Risk Prevention

    Recruiting

    1 1 1 1
    Spain
  • Study on the Effectiveness and Safety of Atorvastatin, Simvastatin, and Fluvastatin in Patients at Risk of Cardiovascular Disease

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Spain

Glossary

  • HbA1c: Hemoglobin A1c, a blood test that measures average blood sugar levels over the past 2-3 months. It's used to diagnose and monitor diabetes.
  • Hyperlipidemia: A condition characterized by high levels of lipids (fats) in the blood, including cholesterol and triglycerides.
  • Impaired Fasting Glucose (IFG): A condition where blood sugar levels are higher than normal when fasting, but not high enough to be diagnosed as diabetes.
  • Glioblastoma: An aggressive type of cancer that occurs in the brain or spinal cord.
  • LDL-C: Low-Density Lipoprotein Cholesterol, often referred to as 'bad' cholesterol. High levels can increase the risk of heart disease.
  • HDL-C: High-Density Lipoprotein Cholesterol, often called 'good' cholesterol. It helps remove other forms of cholesterol from the bloodstream.
  • Triglycerides: A type of fat found in the blood. High levels can increase the risk of heart disease.
  • HOMA IR: Homeostatic Model Assessment of Insulin Resistance, a method used to quantify insulin resistance and beta-cell function.
  • Adiponectin: A protein hormone that regulates glucose levels and fatty acid breakdown.
  • hs-CRP: High-sensitivity C-Reactive Protein, a marker of inflammation in the body.

References

  1. https://clinicaltrials.gov/study/NCT02056847
  2. https://clinicaltrials.gov/study/NCT05977738
  3. https://clinicaltrials.gov/study/NCT03532620